Worth reading
66In focus
Scored from 1 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
683000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Large-scale exercise of the 16th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause)
発行・処分する株式数
683,000 new shares (number of shares delivered on 1 April 2026)
Intended allottee
EVO FUND (the allottee of these Stock Acquisition Rights; the number of shares allotted in connection with this exercise is Not disclosed in the large-scale exercise report)
Terms of the stock acquisition rights
Exercise price
¥416 for the exercise on 1 April 2026. Whether an adjustment clause exists and the adjustment floor are Not disclosed
Number of Stock Acquisition Rights
17,000 issued in total, 11,980 unexercised as of 31 March 2026, and 5,150 currently unexercised
Most recent equity financing
Timing 1 August 2025 / Type Issuance of the 16th Stock Acquisition Rights (with an exercise price adjustment clause), with EVO FUND as the allottee / Amount Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Large-scale exercise of the 16th Stock Acquisition Rights issued through a third-party allotment (with an exercise price adjustment clause) |
| Number of shares to be issued or disposed of | 683,000 new shares (number of shares delivered on 1 April 2026) |
| Intended allottee | EVO FUND (the allottee of these Stock Acquisition Rights; the number of shares allotted in connection with this exercise is Not disclosed in the large-scale exercise report) |
| Total number of issued shares | 7,395,200 shares as of 31 March 2026 → Not disclosed |
| Exercise price | ¥416 for the exercise on 1 April 2026. Whether an adjustment clause exists and the adjustment floor are Not disclosed |
| Number of Stock Acquisition Rights | 17,000 issued in total, 11,980 unexercised as of 31 March 2026, and 5,150 currently unexercised |
| Most recent equity financing | Timing 1 August 2025 / Type Issuance of the 16th Stock Acquisition Rights (with an exercise price adjustment clause), with EVO FUND as the allottee / Amount Not disclosed |
Items this document does not state (21)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company reports that a large-scale exercise took place, but does not state the reason for the exercise or the use of proceeds.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.